StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) shareholders

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
51.7%
5M of 10M shares
Institutional holders
39
11 new, 15 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $0

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Squadron Master Fund LP
Joint filing with Squadron Capital Management LLC (9.60%), Matthew Sesterhenn (9.60%) and 1 more
7,608,6959.60%13G (passive)Mar 31, 2026
Avidity Private Master Fund I LP
Joint filing with Avidity Partners Management LP (9.90%), Avidity Partners Management (GP) LLC (9.90%) and 4 more
4,516,7579.90%13G (passive) amendmentSep 30, 2025
Michael Gregory
Joint filing with Avidity Partners Management LP (9.90%), Avidity Partners Management (GP) LLC (9.90%) and 3 more
4,426,5659.90%13G (passive) amendmentDec 31, 2025
Avidity Master Fund LP
Joint filing with Avidity Partners Management LP (9.90%), Avidity Partners Management (GP) LLC (9.90%) and 4 more
4,211,8709.90%13G (passive) amendmentDec 31, 2024
Great Point Partners, LLC
Joint filing with Dr. Jeffrey R. Jay, M.D. (9.99%), Ms. Lillian Nordahl (9.99%)
4,076,0689.99%13G (passive) amendmentJun 30, 2026
CVI Investments, Inc.
Joint filing with Heights Capital Management, Inc. (6.20%)
3,956,3196.20%13G (passive) amendmentMar 31, 2026
Voting Shares Irrevocable Trust
Joint filing with Federated Hermes, Inc. (8.42%), Thomas R. Donahue (8.42%) and 2 more
3,533,2508.42%13G (passive) amendmentDec 31, 2025
Adage Capital Management, L.P.
Joint filing with Robert Atchinson (9.99%), Phillip Gross (9.99%)
1,041,8249.99%13G (passive)Jun 30, 2026
Heights Capital Management, Inc.
Joint filing with CVI Investments, Inc. (5.90%)
615,5225.90%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SCYXValueChange% of portfolio
Great Point Partners LLC944,2929.49%$3.84M−10.73%
Squadron Capital Management LLC756,8847.61%$3.08M−194,2030.96%
Propel Bio Management, LLC543,4785.46%$2.21MNew1.16%
Adage Capital Partners Gp, L.L.C.543,4785.46%$2.21MNew0.00%
Woodline Partners LP387,5203.89%$1.58MNew0.00%
Vanguard Capital Management LLC296,7472.98%$1.21M+101,1970.00%
Avidity Partners Management LP260,2062.62%$1.06M−260,2100.17%
Kingdon Capital Management, L.L.C.247,8112.49%$1.01M–0.10%
Millennium Management LLC180,7881.82%$735.81K+103,0180.00%
Heights Capital Management, Inc150,5511.51%$612.74K−110,3190.14%
DAFNA Capital Management LLC135,8681.37%$552.98K−20.11%
Empery Asset Management, LP126,4511.27%$514.66K−104,5270.60%
Acadian Asset Management LLC116,6691.17%$473.00K+25,1750.00%
Geode Capital Management, LLC82,0930.83%$334.17K+21,2970.00%
Renaissance Technologies LLC76,5250.77%$311.46K+48,4450.00%
Vanguard Fiduciary Trust Co57,9700.58%$235.94K+29,7530.00%
ADAR1 Capital Management, LLC49,3870.50%$201.01KNew0.01%
BlackRock, Inc.41,5220.42%$169.00K−20.00%
Velan Capital Investment Management LP40,0000.40%$162.80KNew0.10%
Northern Trust Corp22,3850.22%$91.11K+10,4380.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026395M51.7%11 / 1212 / 152M1M
Q1 2026444M40.1%14 / 911 / 63M0M
Q4 2025371M10.9%6 / 107 / 100M1M
Q3 2025421M14.8%7 / 711 / 40M0M
Q2 2025391M14.0%6 / 107 / 60M0M
Q1 2025401M14.6%4 / 713 / 120M0M
Q4 2024482M15.2%11 / 167 / 40M0M
Q3 2024432M16.5%4 / 1211 / 130M0M
Q2 2024532M17.4%8 / 1118 / 90M0M
Q1 2024542M18.7%9 / 1120 / 70M1M
Q4 2023532M23.6%8 / 2210 / 131M0M
Q3 2023602M20.8%16 / 1214 / 80M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

8 funds held SCYX in Q2 2026, 84% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of SCYXValue% of fundAs of
Vanguard Total Stock Market Index Fund152,5421.53%$620.85K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund128,1951.29%$521.75K0.00%Jun 30, 2026
EA Bridgeway Omni Small-Cap Value ETF15,4620.16%$62.93K0.00%Jun 30, 2026
Vanguard Balanced Index Fund5,9100.06%$24.05K0.00%Jun 30, 2026
Dimensional U.S. Small Cap ETF5,1890.05%$25.11K0.00%Jul 31, 2026
U.S. Micro Cap Portfolio4,8310.05%$23.38K0.00%Jul 31, 2026
U.S. Vector Equity Portfolio2,2780.02%$11.03K0.00%Jul 31, 2026
Victory Extended Market Index Fund1,0990.01%$5.32K0.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Gonzalez David AnguloChief Executive Officer, Director1,357,12613.64%Apr 2, 2026
Sanjay SubramanianChief Financial Officer––Sep 11, 2026
ivor MacleodChief Financial Officer398,5294.01%Feb 2, 2026
Scott SukenickChief Legal Officer574,5395.77%Feb 2, 2026
Steven Keith BurkeDirector5,7500.06%Sep 22, 2026
Guy MacdonaldDirector12,6250.13%Jun 30, 2026
Armando AnidoDirector11,7500.12%Jun 30, 2026
Ann HanhamDirector11,5770.12%Jun 30, 2026
Brian Philippe TinmouthDirector12,1250.12%Jun 30, 2026
David C. HastingsDirector11,5220.12%Jun 30, 2026
Steven C. GilmanDirector70,0000.70%Jun 30, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Steven Keith Burke
Director
Sep 18, 2026Award+5,750––5,750
Brian Philippe Tinmouth
Director
Jun 26, 2026Award+2,875––12,125
Ann Hanham
Director
Jun 26, 2026Award+2,875––11,577
Armando Anido
Director
Jun 26, 2026Award+2,875––11,750
Guy Macdonald
Director
Jun 26, 2026Award+2,875––12,625
David C. Hastings
Director
Jun 26, 2026Award+2,875––11,522
Gonzalez David Angulo
Chief Executive Officer, Director
Apr 1, 2026Buy+108,695––1,357,126
Gonzalez David Angulo
Chief Executive Officer, Director
Jan 29, 2026Award+391,333––1,244,431
Scott Sukenick
Chief Legal Officer
Jan 29, 2026Award+129,833––574,539
ivor Macleod
Chief Financial Officer
Jan 29, 2026Award+129,833––398,529
Gonzalez David Angulo
Chief Executive Officer, Director
Oct 17, 2025Award+32,500$0.76$24.70K853,098
Brian Philippe Tinmouth
Director
Jun 26, 2025Award+23,000––74,000
Armando Anido
Director
Jun 26, 2025Award+23,000––71,000
Steven C. Gilman
Director
Jun 26, 2025Award+23,000––70,000
Ann Hanham
Director
Jun 26, 2025Award+23,000––69,622
David C. Hastings
Director
Jun 26, 2025Award+23,000––69,183
Guy Macdonald
Director
Jun 26, 2025Award+23,000––78,000
Gonzalez David Angulo
Chief Executive Officer, Director
Apr 9, 2025Award+23,000$0.84$19.32K816,598
Gonzalez David Angulo
Chief Executive Officer, Director
Mar 20, 2025Award+13,800$1.05$14.49K793,598
Gonzalez David Angulo
Chief Executive Officer, Director
Mar 19, 2025Award+5,000$1.07$5.35K779,798
ivor Macleod
Chief Financial Officer
Jan 23, 2025Award+92,511––260,696
Gonzalez David Angulo
Chief Executive Officer, Director
Jan 23, 2025Award+262,927––770,798
Scott Sukenick
Chief Legal Officer
Jan 23, 2025Award+92,511––436,706
Gonzalez David Angulo
Chief Executive Officer, Director
Sep 12, 2024Buy+20,000$1.37$27.40K507,871
Brian Philippe Tinmouth
Director
Jun 20, 2024Award+23,000––51,000
Armando Anido
Director
Jun 20, 2024Award+23,000––48,000
Steven C. Gilman
Director
Jun 20, 2024Award+23,000––47,000
Guy Macdonald
Director
Jun 20, 2024Award+23,000––55,000
Ann Hanham
Director
Jun 20, 2024Award+23,000––46,622
David C. Hastings
Director
Jun 20, 2024Award+23,000––46,183
Scott Sukenick
Chief Legal Officer
Feb 16, 2024Tax withholding−15,179$1.63$24.74K336,195
Scott Sukenick
Chief Legal Officer
Jan 26, 2024Award+143,675––351,374
Gonzalez David Angulo
Chief Executive Officer, Director
Jan 26, 2024Award+290,590––479,871
ivor Macleod
Chief Financial Officer
Jan 26, 2024Award+143,675––160,185
Ann Hanham
Director
Jun 15, 2023Award+10,000––23,622
David C. Hastings
Director
Jun 15, 2023Award+10,000––23,183
Steven C. Gilman
Director
Jun 15, 2023Award+10,000––24,000
Brian Philippe Tinmouth
Director
Jun 15, 2023Award+10,000––28,000
Guy Macdonald
Director
Jun 15, 2023Award+10,000––32,000
Armando Anido
Director
Jun 15, 2023Award+10,000––25,000
Scott Sukenick
Chief Legal Officer
May 15, 2023Award+50,000––203,599
Scott Sukenick
General Counsel
Jan 27, 2023Award+100,000––153,599
Gonzalez David Angulo
Chief Executive Officer
Jan 1, 2023Award+110,000––185,181
ivor Macleod
Chief Financial Officer
Oct 24, 2022Award+15,000––15,000
David C. Hastings
Director
Jun 17, 2022Award+10,000––13,183
Guy Macdonald
Director
Jun 17, 2022Award+10,000––22,000
Armando Anido
Director
Jun 17, 2022Award+10,000––15,000
Brian Philippe Tinmouth
Director
Jun 17, 2022Award+10,000––18,000
Steven C. Gilman
Director
Jun 17, 2022Award+10,000––14,000
Ann Hanham
Director
Jun 17, 2022Award+10,000––13,622
Marco Taglietti
Chief Executive Officer, Director
Apr 26, 2022Buy+75,000$3.00$225.00K272,068
Scott Sukenick
General Counsel
Apr 26, 2022Buy+3,500$3.00$10.50K53,499
Gonzalez David Angulo
Chief Medical Officer
Feb 4, 2022Award+51,100––74,981
Scott Sukenick
General Counsel
Feb 4, 2022Award+40,700––49,899
Christine Coyne
Chief Commercial Officer
Feb 4, 2022Award+43,200––58,200
Marco Taglietti
Chief Executive Officer, Director
Feb 4, 2022Award+87,200––196,968
Christine Coyne
Chief Commercial Officer
May 10, 2021Award+15,000––15,000
Life Sciences Master Fund Ltd Perceptive
10% owner
Jan 22, 2021Sale−285,151$8.16$2.33M1,833,849
Life Sciences Master Fund Ltd Perceptive
10% owner
Jan 22, 2021Sale−33,849$8.95$302.95K1,800,000
Life Sciences Master Fund Ltd Perceptive
10% owner
Jan 21, 2021Sale−95,000$7.38$701.10K2,120,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
6.02%
0M shares short
Days to cover
5.5
At 0M shares a day
Change since last report
+7.1%
From 0M shares
Short volume, 20 days
55.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Scynexis's stock actually held short. Settlement fails (shares not delivered on time) peaked at 51,927 shares on Sep 29, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
10% Stockholder
Dec 18, 20249,418$11.58KDec 18, 2024Secondary Offering - Open Market
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Dec 18, 2024332,668$409.18KDec 18, 2024Secondary Offering - Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Dec 18, 2024257,914$317.23KDec 18, 2024Secondary Offering - Open Market
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Dec 11, 2024388,113$477.38KDec 11, 2024Secondary Offering-Open Market
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
10% Stockholder
Dec 11, 202410,988$13.52KDec 11, 2024Secondary Offering-Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity FUnds
10% Stockholder
Dec 11, 2024300,899$370.11KDec 11, 2024Secondary Offering - Open Market
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
10% Stockholder
Aug 27, 20249,700$17.17KAug 22, 2024Secondary Offering /Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Aug 27, 2024272,000$481.44KAug 22, 2024Secondary Offering /Open Market
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Aug 27, 2024338,000$598.26KAug 22, 2024Secondary Offering /Open Market
Federated Hermes Kaufmann Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Aug 22, 2024338,000$598.26KAug 22, 2024Secondary Offering / Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Aug 22, 2024272,000$481.44KAug 22, 2024Secondary Offering / Open Market
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
10% Stockholder
Aug 22, 20249,700$17.17KAug 22, 2024Secondary Offering / Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Feb 9, 2024477,101$1.02MFeb 9, 2024Secondary Offering / Open Market
Federated Hermes Kaufmann Small Cap Fund, a portfolio of Federated Hermes Equity Funds
10% Stockholder
Feb 5, 2024590,000$1.26MFeb 5, 2024Secondary Offering / Open Market
Federated Hermes Kaufmann Fund II, a portfolio of Federated Hermes Insurance Series
10% Stock
Sep 22, 20239,214$31.54KSep 21, 2023Secondary Offering / Open Market

See a number that looks wrong?